Mizuho and Evercore ISI Lower Intuitive Surgical Price Targets
Mizuho cut its Intuitive Surgical target to $400 from $415, Evercore ISI to $385 from $400 and kept its In-Line rating. Dow Jones Newswires reports.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Mizuho lowered its price target on Intuitive Surgical shares to $400 from $415. Dow Jones Newswires, citing Benzinga ratings data, reported that Evercore ISI cut its target to $385 from $400 the same day and maintained its In-Line rating.
Both revisions concern the same company and were published about two hours apart. The report includes no new financial figures from the company that would explain the changes.
why it matters
Lower price targets reflect a more cautious analyst view of the stock, but they do not change the ratings. Such moves matter mainly to ISRG shareholders and medical technology investors, with limited impact on the broader market.
tags
instruments
sources
- Intuitive Surgical Price Target Cut to $400.00/Share From $415.00 by Mizuho — Dow Jones Newswires, 21 October 2026 at 12:28 UTC
- Intuitive Surgical Price Target Cut to $385.00/Share From $400.00 by Evercore ISI Group — Dow Jones Newswires, 21 October 2026 at 14:35 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗